Horse Joint therapy helps horse to return to track racing using IRAP

Horse Joint therapy helps horse to return to track racing using Interleukin-1 Receptor Antagonist Protein (IRAP).

A veteran racehorse is a winner again thanks to a novel therapy used by a team at the University of Missouri College of Veterinary Medicine.

In fact, Nate’s Mineshaft, a 5-year-old thoroughbred, has won five times a much since his treatment than before he underwent the groundbreaking therapy.

Nate’s Mineshift developed inflammation around his fetlocks, a joint comparable to the human ankle, causing him serious pain.

The inflammation, which had become the size of softballs when Nate’s Mineshaft arrived at the University of Missouri, prevented him from bending his ankles properly. This condition often leads to racehorses being retired from the racing circuit.

However, university veterinarians performed a new therapy on Nate to reduce the inflammation and prevent further damage to his fetlocks.

The therapy, called Interleukin-1 Receptor Antagonist Protein (IRAP), introduces a helpful protein harvested and magnified from the horse’s blood that helps decrease and prevent inflammation in the horse’s joints.

“During IRAP, we draw the horse’s blood and place it in a syringe with specialized glass beads that stimulate the production of a unique protein during a 24 hour incubation period,” said Shannon Reed, assistant professor of equine surgery and lameness at the College of Veterinary Medicine.

“After 24 hours, the serum with the enhanced protein levels is divided into multiple doses that are injected into the horse’s joint weekly for 4-5 weeks. Because this treatment uses the horse’s own blood, there is no risk of disease transmission or immune rejection from foreign proteins.”

Before receiving treatment at college, Nate’s Mineshaft had won $US58,568 on the track. Since his treatment at MU, Nate has won $US592,806 racing.

In fact, since his recovery, Nate has won five races, including two graded stake races in Louisiana and a graded stakes race in Texas. His performances are earning him widespread media attention.

“It really is a Cinderella story,” Reed said. “Nate was purchased for $US8000 and has won over a half million. His success in the more competitive graded stakes is particularly impressive considering his injuries and his long road back to recovery.”

In addition to the weekly IRAP therapy, University of Missouri veterinarians guided Nate through physical rehabilitation.

Each day, the horse was put through an exercise schedule that consisted of a warm-up, motion exercises, cardio training on a treadmill and a cool down. Nate’s owners credit the MU doctors with the horse’s resurgence.

“They keep up with new treatments, and are on the cutting edge,” said Scott Reiman, co-owner of Nate’s Mineshaft.

“Without Dr Reed and her staff’s excellent care and knowledge of what to do for Nate, he would never have accomplished what he has so far.”

Nate’s Mineshaft will be racing at Churchill Downs in the Grade 1 $US400.000 Stephen Foster Handicap on  June 16 in a bid to qualify for the Breeder’s Cup Classic, considered by many in the racing industry to be the pinnacle of racing success.

Daily horse news and information